Skip Navigation LinksHome > April 2014 - Volume 42 - Issue 4 > Immunological Characterization of Compensatory Anti-Inflamma...
Critical Care Medicine:
doi: 10.1097/CCM.0000000000000100
Feature Articles

Immunological Characterization of Compensatory Anti-Inflammatory Response Syndrome in Patients With Severe Sepsis: A Longitudinal Study*

Gomez, Henry G. MS1; Gonzalez, Sandra M. BS1; Londoño, Jessica M. MD2; Hoyos, Natalia A. MD2; Niño, Cesar D. MD2; Leon, Alba L. BS2,3; Velilla, Paula A. MS, SD1,4; Rugeles, Maria T. MS, SD1,4; Jaimes, Fabián A. MD, MS, PhD2,5,6

Collapse Box


Objectives: To perform a complete immunological characterization of compensatory anti-inflammatory response syndrome in patients with sepsis and to explore the relationship between these changes and clinical outcomes of 28-day mortality and secondary infections.

Design: Prospective single-center study conducted between April 2011 and December 2012.

Setting: ICUs from Hospital Universitario San Vicente Fundación at Medellin, Colombia.

Patients: One hundred forty-eight patients with severe sepsis.

Interventions: None.

Measurements and Main Results: At days 0, 1, 3, 5, 10, and 28, we determined the expression of HLA-DR in monocytes and the apoptosis and the proliferation index in T lymphocytes, as well as the levels of tumor necrosis factor-α, interleukin-6, interleukin-1β, interleukin-10, and transforming growth factor-β in both plasma and cell culture supernatants of peripheral blood mononuclear cells. The mean percentage of HLA-DR+ was 60.7 at enrollment and increased by 0.9% (95% CI, 0.7–1.2%) per day. The mean percentage of CD4 T cells and CD8 T cells AV+/7-AAD– at enrollment was 37.2% and 20.4%, respectively, but it diminished at a rate of –0.5% (95% CI, –0.7% to –0.3%) and –0.3% (95% CI, –0.4% to –0.2%) per day, respectively. Plasma levels of interleukin-6 and interleukin-10 were 290 and 166 pg/mL and decreased at a rate of –7.8 pg/mL (95% CI, –9.5 to –6.1 pg/mL) and –4 pg/mL (95% CI, –5.1 to –2.8 pg/mL) per day, respectively. After controlling for confounders, only sustained plasma levels of interleukin-6 increase the risk of death (hazard ratio 1.003; 95% CI, 1.001–1.006).

Conclusions: We found no evidence to support a two-phase model of sepsis pathophysiology. However, immunological variables did behave in a mixed and time-dependent manner. Further studies should evaluate changes over time of interleukin-6 plasma levels as a prognostic biomarker for critically ill patients.

© 2014 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.